Article citationsMore>>
Cooper, L.T., Hare, J.M., Tazelaar, H.D., Edwards, W.D., Starling, R.C., Deng, M.C., Menon, S., Mullen, G.M., Jaski, B., Bailey, K.R., Cunningham, M.W., Dec, G.W. and Giant Cell Myocarditis Treatment Trial Investigators (2008) Usefulness of Immunosuppression for Giant Cell Myocarditis. American Journal of Cardiology, 102, 1535-1539.
http://dx.doi.org/10.1016/j.amjcard.2008.07.041
has been cited by the following article:
-
TITLE:
Idiopathic Giant Cell Myocarditis: State of the Art
AUTHORS:
Alessia Veia, Chiara Cavallino, Sara Bacchini, Fabio Pastore, Alessandro Lupi, Andrea Rognoni, Francesco Rametta, Angelo Sante Bongo
KEYWORDS:
Giant Cell, Myocarditis Endomyocardial Biopsy, Heart Failure, Immunosuppression
JOURNAL NAME:
World Journal of Cardiovascular Diseases,
Vol.4 No.6,
May
30,
2014
ABSTRACT: Giant cell myocarditis (GCM) is a rare, rapidly progressive and highly lethal disease in young and middle-aged adults. It is attributed to an inflammation of the heart muscle, and mediated by T lymphocytes and anti-myosin autoantibodies. Making diagnosis of GCM with multiple noninvasive imaging modalities is possible in a small percentage of patients, so myocardial tissue diagnosis is often required. An early diagnosis is very important, because immunosuppressive treatment may significantly improve clinical course and survival of these patients. GCM often escapes diagnosis until autopsy or transplantation and has defied proper treatment trials for its rarity and deadly behavior. This review will focus on the diagnostic approach to patients with suspected GCM and currently evidence-based treatment strategy for this disease.
Related Articles:
-
Miguel Ángel Garcés-Villalá, Sergio David Rico, Mariano Escudero-Pinel, José Luis Calvo-Guirado
-
Tomoaki Torigoe, Atsuhiko Terakado, Yoshiyuki Suehara, Taketo Okubo, Tatsuya Takagi, Kazuo Kaneko, Yasuo Yazawa
-
Iskander Al-Githmi
-
Timur Selcuk Akpinar, Busra Alpaslan, Raim Iliaz, Goknur E. Isik, Bulent Saka
-
Sankar Rao. P, Siddaram Patil, Sandeep Reddy